Showing results (281-290 of 289) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 289 results.
Scientific Reports|June 14, 2023
Knowledge, attitudes and intention on fertility preservation among breast cancer patientsJennifer K Y Ko, Charleen S Y Cheung, Heidi H Y Cheng, et al.
Nano Letters|July 9, 2024
Antimony-Platinum Modulated Contact Enabling Majority Carrier Polarity Selection on a Monolayer Tungsten Diselenide ChannelYu-Tung Lin, Ching-Hao Hsu, Ang-Sheng Chou, et al.
Cancer Research and Treatment|June 6, 2019
BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 TherapySung-Bae Kim, In-Gu Do, Janice Tsang, et al.
Molecular Neurobiology|February 10, 2023
Ndufa4 Regulates the Proliferation and Apoptosis of Neurons via miR-145a-5p/Homer1/Ccnd2Fang Fu, Chen Chen, Kun Du, et al.
Clinical Medicine Insights. Oncology|January 27, 2025
Modifiable Risk Factors Including Self-Perceived Stress for Breast Cancer in Hong Kong: A Case-Control Study of 10 757 SubjectWinnie Yeo, Lok-Wa Yuen, Kelvin Kam-Fai Tsoi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 9, 2026
Post-authorization safety study to assess the risk of diabetic ketoacidosis among type 2 diabetes mellitus patients treated with ertugliflozin compared to patients treated with other antihyperglycaemic agents in a Medicare and Medicaid populationAshish Rai, James Marshall, Sampada Nandyala, et al.
National Science Review|July 9, 2026
Li<sup>+</sup> intercalation chemistry on 2D transition metal dichalcogenides towards phase evolution, scalable production, and applicationQingyong Zhang, Jian Jiang, Ruixin Yan, et al.
Breast Cancer Research and Treatment|September 23, 2021
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimensMing Shen Dai, Yin Hsun Feng, Shang Wen Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 16, 2016
Crowdsourced estimation of cognitive decline and resilience in Alzheimer's diseaseGenevera I Allen, Nicola Amoroso, Catalina Anghel, et al.
Pageof 29